Reckitt's Delsym Brand Launches 'Cough-tastrophe' Campaign with AJ McLean
Reckitt's Delsym brand has partnered with artist AJ McLean for a new marketing campaign aimed at highlighting the impact of unexpected coughs.
Stocks · News reference
Cramer favors Howmet, remains cautious on AeroVironment, Rocket, AtaiBeckley and MP Materials, citing competition and limited upside.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Reckitt's Delsym brand has partnered with artist AJ McLean for a new marketing campaign aimed at highlighting the impact of unexpected coughs.
Rocket Companies reported $2.6 billion in adjusted Q3 2026 revenue and $419 million in adjusted net income despite a severe mortgage market contraction. The company is leveraging AI-powered loan conversion tools that convert refinance applicants at 4x the standard rate, with over 70% of revenue coming from less rate-sensitive sources like loan servicing. With $11.4 billion in liquidity and net corporate leverage below 1 turn, Rocket maintains a strong balance sheet to capture market share during industry downturns.
Ondas Inc. (ONDS) raised its 2026 revenue guidance to at least $550M following Q3 revenues of $167.5M, up 16-fold year-over-year. The company expects Q4 revenues exceeding $250M, supported by an $835M backlog and $214M in new orders. However, adjusted gross margins declined to 34.8% and adjusted EBITDA losses widened to $59.7M, signaling profitability challenges despite strong top-line growth.
Ondas Holdings (ONDS) targets $550M in 2026 revenues and $1.1B in 2027 with organic growth above 40%, backed by an $835M backlog. However, the company faces widening EBITDA losses, rising costs, and M&A integration challenges. Analysts recommend a hold-and-watch approach pending evidence of operating leverage and profitability.
Ondas Inc. (ONDS) reported Q3 2026 revenues of $167.5 million with an $835 million backlog, raising 2026 guidance to $550 million and 2027 target to $1.1 billion. However, the stock fell 17.8% post-earnings due to widening EBITDA losses ($59.7 million), gross margin compression (21.8%), and significant cash burn ($278 million in nine months). While the company benefits from strong defense demand and acquisition-driven growth, execution risks and profitability challenges warrant caution.
Barclays has updated its outlook on Reckitt Benckiser Group plc, maintaining an "Overweight" rating while increasing the company's price target.